ATI Physical Therapy, Inc.
ATI Physical Therapy, Inc. (ATIP) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
atip · stock forecast · 5 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Hold
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$175
Consensus
$104
+15270.4% upside
Low
$32.50
Median: $103.75 · Last Close: $0.68
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.68 | ↑ 0.00% |
1-day model range: $0.68–$0.68. Peak: $0.68 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ATIP · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-11-16 | Deutsche Bank | Maintains | Hold→Hold |
| 2022-11-10 | Benchmark | Downgrade ↓ | Buy→Hold |
| 2022-11-08 | Citigroup | Maintains | Neutral→Neutral |
| 2022-10-27 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2022-08-10 | Benchmark | Maintains | Buy→Buy |
| 2022-04-06 | Deutsche Bank | Maintains | Hold→Hold |
| 2022-01-14 | Jefferies | Upgrade ↑ | Hold→Buy |
| 2021-07-27 | Benchmark | Downgrade ↓ | Buy→Hold |
| 2021-07-27 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2021-07-27 | Jefferies | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on ATI Physical Therapy, Inc. (ATIP) stock. Of the recent 11 rating actions, 1 were upgrades and 6 were downgrades. 5 analysts currently cover ATIP.
Analyst Recommendation Trends
ATIP analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$628M
↓ 12.5% YoY
Revenue Next Year
$637M
↑ 1.5% YoY
EPS This Year
$-184.50
EPS Next Year
$-32.07
↓ 82.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast ATIP EPS of $-184.50 for the current fiscal year, based on estimates from 1 analysts. The ATIP revenue forecast is $628M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ATIP stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ATIP price target is $103.75 (+15270.4% upside), with an analyst consensus of Hold.
The ATIP short-term stock prediction for tomorrow is $0.68 (+0.00%).
ATI Physical Therapy, Inc. trades on OTC under the ticker ATIP. The ATIP stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
ATIP forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month ATIP price target is $103.75, with a high forecast of $175.00 and a low of $32.50. The median price target is shown in the chart above when available. This implies +15270.4% potential upside from the current price of $0.68.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.